Erytech Pharma Culls Work On Late-Stage Leukemia Asset, Evaluates Partnership Options
August 25, 2022 at 06:35 AM EDT
Erytech Pharma SA(NASDAQ: ERYP)will no longer seek approvalfor Graspa in hypersensitive acute lymphoblastic ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.